E

Entrada Therapeutics

Develops intracellular therapeutics using endosomal escape

Manager – Commercial Strategy Analytics

Corporate StrategyConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$126.8k - $166.5k

About the Job

Requirements

  • A bachelor’s degree in a life sciences discipline is required.
  • At least 5 years of relevant experience is required, preferably in market research, equity research, life sciences consulting, commercial analytics, or biotech/pharma.
  • Direct experience synthesizing and communicating competitive insights from drug development programs or companies is required.
  • Strong analytical skills and a broad understanding of the life sciences business and research and development process are required.
  • Experience building and interpreting financial models and communicating modeling outputs to support strategic decision-making is required.
  • Familiarity with the rare disease space is required.
  • The candidate must be able to engage with external experts and internal stakeholders to gather insights and feedback.
  • The candidate must be able to work in a fast-paced, collaborative environment and adapt to new findings and team input.
  • The candidate must be based out of the Boston headquarters office and work there 2–3 days per week.

Responsibilities

  • Support development of asset-level and portfolio-level pre-commercial or commercial readiness analyses across target indications and geographies.
  • Conduct market sizing, epidemiology, competitive landscape, and pricing and reimbursement analyses.
  • Build and maintain revenue forecast models incorporating insights from the evolving clinical, regulatory, and market landscape.
  • Support continued development of existing initiatives across the corporate strategy team.
  • Gather and capture market data to support data-driven analyses, generate strategic insights, and communicate findings efficiently.
  • Conduct primary and secondary market research to gather data for insights and analyses that support Entrada’s pre-commercial strategy.
  • Distill market insights and data in a timely manner to generate strategic takeaways and recommendations for key decision makers across the organization.

Desired Qualifications

  • A PhD, MBA, or other advanced degree is strongly preferred.

About the Company

Entrada Therapeutics

Develops intracellular therapeutics using endosomal escape

Entrada Therapeutics focuses on developing a new class of medicines to treat devastating diseases by delivering therapies inside cells. Its core technology, the Endosomal Escape Vehicle (EEV) platform, helps drugs escape from endosomes—cellular compartments that often trap or degrade treatments—so they can reach intracellular targets. The product pipeline centers on EEV-therapeutics, including candidates for Duchenne muscular dystrophy and other neuromuscular diseases, with ENTR-601-45 currently cleared by UK and EU regulators to begin clinical trials. What sets Entrada apart is its explicit emphasis on enabling intracellular delivery to access targets that were previously hard to treat, using a platform-agnostic delivery approach that can work with a range of therapeutics such as oligonucleotides. The company’s goal is to advance multiple EEV-therapeutics through clinical development to address rare and other hard-to-treat diseases and reach patients who need new treatment options.

Company size
201-500
Company stage
IPO
Headquarters
Boston, MA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Entrada Therapeutics

See more jobs